Most Popular
-
1
Jung's paternity reveal exposes where Korea stands on extramarital babies
-
2
Samsung entangled in legal risks amid calls for drastic reform
-
3
Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul
-
4
[Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'
![[Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/26/20241126050017_0.jpg&u=20241126161719)
-
5
Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
![[Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/26/20241126050017_0.jpg&u=20241126161719)
-
6
[Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle
![[Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/26/20241126050043_0.jpg&u=20241126145342)
-
7
Seoul blanketed by heaviest Nov. snow, with more expected
-
8
K-pop fandoms wield growing influence over industry decisions
-
9
[Graphic News] International marriages on rise in Korea
![[Graphic News] International marriages on rise in Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050091_0.gif&u=)
-
10
Korea's auto industry braces for Trump’s massive tariffs in Mexico
![[Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/26/20241126050043_0.jpg&u=20241126145342)
![[Graphic News] International marriages on rise in Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050091_0.gif&u=)
[THE INVESTOR] Korean pharma companies Green Cross Labcell and ST Pharm will list on the secondary bourse KOSDAQ on June 23, the Korea Exchange announced on June 22.
Green Cross Labcell, a Green Cross affiliate that develops drugs for incurable diseases, posted 34.5 billion won (US $29.8 million) in sales and operating profit of 2.3 billion won last year. The initial public offering is priced at 18,500 won.
ST Pharm, launched in 2008, recorded 138 billion won in sales and 25.2 billion won in operating profit last year. The IPO is priced at 29,000 won.
By Ahn Sung-mi (sahn@heraldcorp.com)
Green Cross Labcell, a Green Cross affiliate that develops drugs for incurable diseases, posted 34.5 billion won (US $29.8 million) in sales and operating profit of 2.3 billion won last year. The initial public offering is priced at 18,500 won.
ST Pharm, launched in 2008, recorded 138 billion won in sales and 25.2 billion won in operating profit last year. The IPO is priced at 29,000 won.
By Ahn Sung-mi (sahn@heraldcorp.com)
